ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,715Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 2343

$933K Total Retail Price of All Prescriptions

Rank: 158 out of 2343

476 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 17,409 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 800 732 1 2
WARFARIN SODIUM 673 658 2 8
OMEPRAZOLE 667 622 3 4
SIMVASTATIN 640 564 4 1
ATENOLOL 622 566 5 12
PRAVASTATIN SODIUM 522 513 6 15
AMLODIPINE BESYLATE 521 507 7 5
LISINOPRIL 474 418 8 3
BUMETANIDE 396 370 9 91
METOPROLOL TARTRATE 370 342 10 7
DIGOXIN 297 286 11 35
METFORMIN HCL 291 273 12 9
SERTRALINE HCL 283 277 13 20
FUROSEMIDE 265 250 14 6
POTASSIUM CHLORIDE 263 227 15 18
ATORVASTATIN CALCIUM 262 250 16 10
METOPROLOL SUCCINATE 261 232 17 14
JANTOVEN 248 206 18 81
LOSARTAN POTASSIUM 242 237 19 19
ZETIA 236 223 20 52
SYNTHROID 235 217 21 40
DIOVAN 231 208 22 23
ISOSORBIDE MONONITRATE ER 201 190 23 32
RANITIDINE HCL 197 186 24 43
GLIMEPIRIDE 192 179 25 45
CLOPIDOGREL 189 181 26 26
FLUTICASONE PROPIONATE 173 160 27 46
HYDROCHLOROTHIAZIDE 171 140 28 11
ALLOPURINOL 167 160 29 31
DONEPEZIL HCL 166 166 30 21
GABAPENTIN 164 138 31 16
CLONIDINE HCL 148 148 32 70
LANTUS 147 120 33 51
JANUVIA 144 144 34 50
PANTOPRAZOLE SODIUM 143 118 35 22
CRESTOR 142 133 36 30
ALENDRONATE SODIUM 127 105 37 28
KLOR-CON M10 121 121 38 107
HYDROCODONE-ACETAMINOPHEN 108 106 S3 39 13
BENICAR 107 94 40 93
TAMSULOSIN HCL 106 103 41 29
CARVEDILOL 103 102 42 27
LIPITOR 102 102 43 78
CEPHALEXIN 101 100 44 111
PLAVIX 100 95 45 38
AZITHROMYCIN 95 84 46 39
NAMENDA 93 93 47 36
VERAPAMIL ER 92 83 48 95
RISPERIDONE 90 79 49 61
TRAMADOL HCL 88 88 50 25
HUMALOG 86 73 51 131
KLOR-CON M20 86 66 51 44
ADVAIR DISKUS 83 80 53 34
PROPRANOLOL HCL 83 72 53 132
DIVALPROEX SODIUM 81 73 55 105
AMLODIPINE BESYLATE-BENAZEPRIL 80 80 56 59
NOVOLOG MIX 70-30 77 77 57 257
CITALOPRAM HBR 76 76 58 17
ESCITALOPRAM OXALATE 76 76 58 55
KLOR-CON 10 76 76 58 134
NOVOLOG 75 75 61 110
COMBIVENT 74 71 62 144
POLYETHYLENE GLYCOL 3350 69 68 63 54
NEXIUM 68 56 64 33
LABETALOL HCL 68 65 64 153
LEVETIRACETAM 67 57 66 104
DIOVAN HCT 66 66 67 63
NATEGLINIDE 66 66 67 255
PREDNISONE 64 55 69 37
AMOXICILLIN 61 52 70 118
INDAPAMIDE 61 54 70 170
THEOPHYLLINE ANHYDROUS 60 60 72 231
MIRTAZAPINE 58 58 73 41
LOVASTATIN 57 45 74 47
TRAMADOL HCL-ACETAMINOPHEN 56 55 75 199
PAROXETINE HCL 56 56 75 66
OLANZAPINE 52 42 77 121
SOTALOL 51 51 78 177
MELOXICAM 51 50 78 68
FELODIPINE ER 51 46 78 116
AMIODARONE HCL 51 39 78 158
CARBAMAZEPINE 50 39 82 206
ACTOS 50 50 82 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.